KALA BIO, Inc.

KALA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $139.4M

Liabilities Breakdown FY2021

Total Liabilities: $122.6M